Only in Titles

Search results for: Small

paperclip

Error loading info... Pleas try again later.
paperclip

#36183218   2022/07/04 To Up

Contribution of cabotegravir + rilpivirine long-acting for the treatment of HIV-1 infection.

To determine the value contribution of cabotegravir + rilpivirine, the first injectable every two months long-acting antiretroviral  regimen, using multi-criteria decision analysis.
Miguel Ángel Calleja-Hernández, José Manuel Martinez-Sesmero, Laura Amanda Vallejo-Aparicio, Beatriz Hernández-Novoa, Xavier Badia

2453 related Products with: Contribution of cabotegravir + rilpivirine long-acting for the treatment of HIV-1 infection.